The findings from our mouse models are complimentary and together these models indicate that expression of ALS-linked ubiquilin-2 mutants cause progressive ubiquilin-2 pathology involving aggregate formation and proteinopathy. The gene discussed is UBQLN2; the disease is amyotrophic lateral sclerosis.